KEYWORDS spinal tumor; ependymoma; fluorescein sodium; neurosurgery Spinal ependymomas (SEs) are common adult intramedullary tumors; however, determining the absolute boundary between the tumor and the tumor residual may be difficult. We assessed outcomes following the use of fluorescein sodium (FS) during surgical removal of SEs. We performed a retrospective analysis of 112 patients with SEs who were treated at Beijing Tsinghua Changgung Hospital between December 2014 and December 2016. Each patient received intravenous FS (3-4 mg/kg) to determine the SE boundaries during surgery. Tumor removal efficiencies and tumor residuals were assessed using magnetic resonance imaging (MRI) at 10 days and 3 months after surgical recovery; McCormick's spinal function classification was also performed at the 3-month follow-up. The complete tumor removal rate was 92% (103/112). Ninetyfour patients underwent tumor removal under fluorescent light, which provided distinctive tumor fluorescence. Tumor removal under white light was performed in 18 patients; fluorescent images were invisible or indistinctive in these 18 patients. At the 3-month follow-up, sensory function (85.8% (91/106)) and movement (84.3% (86/102)) were improved in patients with pre-surgical dysfunction; urination and defecation functions were improved in 66.7% (16/24). The McCormick spinal cord functional classifications, at the 3-month follow-up, showed significant differences in the percentages of patients with disease classified to each grade (I-IV), compared with preoperative classifications (each, P < 0.05). There was no MRI evidence of tumor relapse or residuals at the 3-month follow-up. FS use during the surgical treatment of SE enables complete tumor removal and detection of tumor residuals. Jing LK, et al. Fluorescein sodium use during spinal ependymoma resection. Transl. Neurosci. Clin. 2017, 3(3): 123-134.
Introduction
Spinal ependymomas (SEs) are the most common type of adult intramedullary tumor. SEs arise from ependymal epithelial cells at the center of the spinal cord, and often develop in the cervical cord [1] [2] [3] [4] [5] . SEs present with slow, longitudinal growth along the spinal cord and show expandability. Most SEs have clear boundaries, and surgical removal of the whole tumor is the primary treatment option [6] [7] [8] [9] [10] . However, absolute tumor boundaries can be difficult to determine, particularly in patients with tumor-associated strokes. Further, the spinal cord has numerous septa that tightly adhere to the cord, making tumor boundary determination and tumor residual detection difficult. Thus, assessing tumor boundaries and detecting tumor residuals during surgery is challenging. In the present study, we performed a retrospective study on the outcomes of fluorescein sodium (FS) use during surgical removal of SEs.
Materials and methods

Clinical documentation
Spinal tumor patients (n = 193) admitted to Beijing Tsinghua Changgung Hospital and followed-up between December 2014 and December 2016 were included. Of these, 112 cases of SE were pathologically confirmed (78 men, 34 women; age range, 28-67 years; mean age, 41.3 ± 5.6 years). Prior to surgery, 106 patients exhibited sensory disorders in one (unilaterally) or two (bilaterally) limbs; 102 patients had movement disorders in all four extremities (including 92 with decreased muscle strength), five patients had lower limb paralysis (including two patients with sudden paralysis due to strokes, confirmed using magnetic resonance imaging (MRI)), four patients had respiratory dysfunction, and 24 patients had voiding dysfunction/ obstructed defecation. Preoperative McCormick spinal cord evaluations showed that 14 patients were at grade I, 35 at grade II, 54 at grade III, and nine at grade IV.
Imaging findings
All patients underwent 3.0-T MRI examinations; lesions were observed in the cervical cord (86 patients), thoracic spine (18), conus medullaris (5) , and filum terminale (3). The lesions involved 1-2 segments (12 patients), 3-4 segments (58), 5-6 segments (26), or ≥7 segments (16) (Figures 1-3 ). There were 90 patients with combined syringomyelia, 94 with increased tumor solidification, 14 with intramedullary tumor-associated stroke and heterogeneous tumor solidification, and four with unchanged tumor solidification.
Surgical protocol
Patients received FS (3-4 mg/kg intravenous; Lishede, Alcon, Fort Worth, TX, USA), 30 min before receiving general anesthesia. A Meditec Pentero 900 microscope (Carl Zeiss, Jena, Germany) equipped with a 560-nm, yellow fluorescence source was used for tumor imaging. Body positioning was determined by the tumor position. During each surgery, the somatosensory evoked potentials and surface electromyograms of the four extremities were monitored. Based on the tumor location and number of involved segments, a medial route via the posterior neck was adopted to expose the laminas along the upper and lower tumor boundaries. The corresponding laminas were then opened and removed with an ultrasound bone scalpel to further expose the dura mater. The dura mater was cut and lifted, followed by cutting of the arachnoid mater.
Each tumor's appearance and boundaries were microscopically observed under white light. During surgery, yellow fluorescence (560 nm) was used to image the tumor. A short posteromedial incision was made on the spinal cord to avoid causing tumor bleeding that would blur the tumor boundaries. The tumor boundaries were completely exposed. The majority of the tumors had visible boundaries and could be removed. However, tumor removal was relatively difficult in patients who had experienced tumor-associated strokes, and required careful surgery to avoid excessive traction and basal spinal cord damage. Tumor removal was performed with proper management of hemostasis. During surgery, tumors were exposed, imaged, and removed under alternating white and fluorescent illumination.
After completing tumor removal, fluorescence was also used to look for tumor residuals, particularly at the tops and bottoms of the cysts, and along the cyst walls. After the tumors were removed, the pia and dura maters were sutured closed. Suturing of the arachnoid was dependent on the existing conditions. The laminas that had been removed were replaced and stabilized using two-hole connectors from the craniomaxillofacial device. Layered closure was then performed, and postoperative respiration and movement were monitored.
Outcome evaluation
Clinical function changes, McCormick grading [11] , tumor status, and complications (based on MRI examinations) were monitored at postoperative day 7 and months 1 and 3.
Statistics
All data analyses were performed using statistical software (SAS v9.3; IBM, Armonk, NY, USA). Quantitative data are expressed as means ± standard deviations; count data are expressed as percentages or constituent ratios. The chi-square test was used to determine differences in postoperative functional improvements, and the rank sum test was used to assess differences in the McCormick spinal function; P < 0.05 was considered statistically significant.
Results
Intraoperative tumor status
In the absence of FS, 80 patients demonstrated clear tumor boundaries and 32 had blurry tumor boundaries resulting from tumor adhesion to the spinal cord, including 14 with severe adhesions and intramedullary tumor-associated strokes (Figures 1-3) . Under fluorescence, tumors were visible in 94 patients and invisible or indistinct in 18, including 14 with intramedullary tumor-associated strokes and indistinct MRI enhancement and four without MRI enhancement. Under fluorescence, complete tumor removal was accomplished in 92% (103/112) of the patients. Of the nine patients with tumors that could not be completely removed, five had myxopapillary ependymomas at the conus medullaris and four also had strokes and severe adhesions.
Functional recovery
Three months after surgery, sensory function and movement were improved in most patients demonstrating preoperative dysfunction (Tables 1 and 2) . By 3 months after surgery, sensory function and movement were improved in most patients who had developed preoperative dysfunction or had demonstrated postoperative aggravation of their dysfunction. Of these patients, the rate of improved urination/ defecation function was 71.4% (10/14). Urination and defecation functions were unchanged at the 3-month follow-up, compared with functioning at postoperative day 7 and 1 month (P > 0.05). Surgery did not cause new cases of respiratory dysfunction.
Comparison of imaging and intraoperative fluorescence findings
Of the 112 cases, 94 (83.9%) had enhanced preoperative MRIs and distinct intraoperative fluorescent images, four had indistinct MRI enhancements and fluorescent images during surgery, and 14 had tumor-associated strokes associated with non-uniform MRI enhancement and indistinct fluorescent imaging, intraoperatively (Figure 3) . The present study included 90 patients with combined syringomyelia, 88 of whom did not present with cyst wall enhancement during either their preoperative MRI examinations or with intraoperative fluorescent cyst walls, and one who presented with preoperative cyst wall MRI enhancement and intraoperative fluorescent cyst wall images.
Spinal cord functional classification improvement
The 
Discussion
FS is widely used for improving the diagnosis of malignant tumors and vascular lesions, although mainly in eye disease. The use of FS for the location and removal of an intracranial tumor was first reported in 1948 [12] [13] [14] [15] [16] . However, the requirement for advanced imaging technology and the lack of specificity in the obtained images limited its applications. Under physiological conditions, circulating FS does not typically cross the blood-brain barrier to enter the brain. However, FS can accumulate within neurovascular tumors following endothelial lesions, and is visible under 560-nm yellow light [12] . Factors affecting the use of FS include malignant tumors, vascular permeability defects, blood-brain barrier defects, and angiogenesis [14, 15] . FS has a low molecular weight and reversibly binds to hemoglobin and red blood cells. Therefore, FS can permeate extravascular regions and stain the tissues surrounding a tumor. Recent studies have shown that fluorescent hemoglobin conjugates can also increase tumor contrast [16] . Thus, FS can increase tumor visibility and improve the range of tumor removal. Nevertheless, FS imaging reliability requires further improvement, particularly for determining tumor boundaries and for prognostic evaluations [16] . Therefore, in the present study, we examined the use of FS in surgeries treating SEs.
In the present study, all 112 patients with SEs underwent FS-assisted tumor removal, and 94 (83.9%) had distinctive fluorescent imaging findings that aided complete tumor removals. There were 18 patients (16.1%) with indistinct fluorescent tumor images, and the tumors were removed under white light. Koc et al. reported a significantly higher rate of complete glioma removal, from the brain, when using FS (83%), compared with the rate obtained when FS was not used (55%); there were no differences in survival rates [11] . Shinoda et al. also reported an increase in the rates of complete removal of brain gliomas when using FS (84.4%) than when using conventional white light (30.1%) [13] . Theoretically, ependymomas and normal spinal tissues have clear boundaries, allowing for surgical removal of intact tumors. However, this procedure is difficult in patients with tumor-associated strokes, myxopapillary ependymomas at the conus medullaris, or anaplastic ependymomas. In the present study, the rate of complete ependymoma removal when using FS was 92%, higher than that previously reported for FS-assisted complete brain glioma removals. The McCormick classification showed that spinal function was improved at postoperative day 1 and at the 1-and 3-month follow-ups. Although surgery was associated with temporary sensory (n = 88) and movement (n = 46) dysfunctions, these conditions were improved at the 3-month postoperative follow-ups (improvement rates of 79.5% (70/88) and 87% (40/46), respectively). Thus, both preoperative and surgeryassociated dysfunctions improved during follow-up. Preoperative respiratory dysfunction showed varying degrees of postoperative improvement, possibly because of pressure relief on the spinal cord following tumor removal, and improved blood supply. Patients with tumor-associated, preoperative strokes and paralysis (n = 5) demonstrated suboptimal postoperative improvements, indicating that the surgery timing requires optimization to prevent paralysis and other severe dysfunctions. These observations also indicated that, after paralysis, surgery is still beneficial, although the outcomes are suboptimal. During followup, there was no MRI evidence of tumor residuals or relapses. However, long-term follow-up studies are required to fully monitor tumor relapse.
For patients with tumor-associated stokes, white light is required intraoperatively to detect and remove the tumors. However, hemosiderin deposits can cause tumor cells to tightly adhere to normal spinal cords, increasing the difficulty of assessing tumor boundaries and residuals under both white light and fluorescent illumination. Hyperplasia of small blood vessels increases the blood supply to tumors, which also makes surgery more difficult. In the present study, one patient presented with cysts at both ends of the tumor (determined using MRI) and at the cyst wall (evidenced using intraoperative fluorescent imaging), indicating possible tumor cell infiltration and metastasis.
In summary, fluorescent imaging and preoperative MRI enhancement imaging are useful for detecting tumor infiltration and metastasis. In particular, we found that FS was useful for intraoperative SE removal. Further, a combination of white light and fluorescent microscopic imaging helps visualize tumors and tumor residuals, increasing the resection rate. However, tumors invisible under intraoperative fluorescence still require normal white light for detection. Further, there was no benefit of intraoperative fluorescent imaging for patients with tumor-associated stokes. Further studies in more patients are required to analyze the correlation of MRI imaging with intraoperative fluorescent imaging, and to assess the reliability of this technique, including the sensitivity and specificity of tumor imaging to decrease imaging noise resulting from swollen cells surrounding a tumor. Additionally, studies examining the effects of FS on tumor removal ranges and survival rates are required. resection under the YELLOW 560 nm surgical microscope filter in malignant brain tumor surgery-a feasibility study. Acta Neurochir 2013, 155 (4) Dr. Wang has previously mentored by renown neurosurgeon and academician Zhongcheng Wang and has more than 25 years of experience in the surgical treatment of brain stem and spinal cord tumors, spinal congenital dysplasia, and spinal degeneration diseases.
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